Viewing Study NCT01656850


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2025-12-29 @ 4:02 AM
Study NCT ID: NCT01656850
Status: COMPLETED
Last Update Posted: 2016-11-16
First Post: 2012-01-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Effect of Whole Almonds on Biomarkers of Cardiovascular Disease in Chinese Patients With Type 2 Diabetes
Sponsor:
Organization:

Raw JSON

{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D003924', 'term': 'Diabetes Mellitus, Type 2'}, {'id': 'D006943', 'term': 'Hyperglycemia'}, {'id': 'D006946', 'term': 'Hyperinsulinism'}], 'ancestors': [{'id': 'D003920', 'term': 'Diabetes Mellitus'}, {'id': 'D044882', 'term': 'Glucose Metabolism Disorders'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'liujenfa@mail.cgust.edu.tw', 'phone': '+886-3-2118999', 'title': 'Liu, Jen-Fang', 'phoneExt': '5487', 'organization': 'Taipei Medical University'}, 'certainAgreement': {'piSponsorEmployee': False, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'timeFrame': 'one week for each intervention', 'eventGroups': [{'id': 'EG000', 'title': 'Whole Almond Diet', 'description': 'participants received experiment diet containing 20% calorie from whole almond', 'otherNumAtRisk': 33, 'otherNumAffected': 0, 'seriousNumAtRisk': 33, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'NCEP Diet', 'description': 'participants received NCEP diet for 3 months', 'otherNumAtRisk': 33, 'otherNumAffected': 0, 'seriousNumAtRisk': 33, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'The Major Nutrients of NCEP Step 2 Diet and Almond Diets', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Whole Almonds', 'description': 'whole almonds to replace 20% daily calorie intake\n\nwhole almonds: Whole almonds will be incorporated into a control diet which is a NCEP step 2 diet. Whole almonds will replace 20% daily calorie intake.'}, {'id': 'OG001', 'title': 'NCEP Step 2 Diet', 'description': 'follow NCEP step 2 diet\n\nNCEP Step 2 diet: follow NCEP step 2 diet'}], 'classes': [{'title': 'Crude protein', 'categories': [{'measurements': [{'value': '17.5', 'spread': '1.3', 'groupId': 'OG000'}, {'value': '17.2', 'spread': '1.6', 'groupId': 'OG001'}]}]}, {'title': 'Fat', 'categories': [{'measurements': [{'value': '38.4', 'spread': '3.5', 'groupId': 'OG000'}, {'value': '29.2', 'spread': '3.1', 'groupId': 'OG001'}]}]}, {'title': 'Carbohydrate', 'categories': [{'measurements': [{'value': '47.0', 'spread': '3.4', 'groupId': 'OG000'}, {'value': '55.7', 'spread': '4.3', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.0001', 'groupIds': ['OG000', 'OG001'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'the entire study, up to 3 months', 'unitOfMeasure': '% of energy', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Lipid Profiles at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'title': 'HDL', 'categories': [{'measurements': [{'value': '44.8', 'spread': '12.9', 'groupId': 'OG000'}, {'value': '49.7', 'spread': '13.4', 'groupId': 'OG001'}, {'value': '45.2', 'spread': '11.9', 'groupId': 'OG002'}, {'value': '48.5', 'spread': '12.4', 'groupId': 'OG003'}]}]}, {'title': 'LDL', 'categories': [{'measurements': [{'value': '97.5', 'spread': '29.3', 'groupId': 'OG000'}, {'value': '102.9', 'spread': '29.2', 'groupId': 'OG001'}, {'value': '100.2', 'spread': '29.5', 'groupId': 'OG002'}, {'value': '98.0', 'spread': '24.5', 'groupId': 'OG003'}]}]}, {'title': 'Total cholesterol', 'categories': [{'measurements': [{'value': '170.7', 'spread': '31.9', 'groupId': 'OG000'}, {'value': '180.6', 'spread': '36.0', 'groupId': 'OG001'}, {'value': '175.1', 'spread': '36.0', 'groupId': 'OG002'}, {'value': '178.9', 'spread': '28.4', 'groupId': 'OG003'}]}]}, {'title': 'Triglyceride', 'categories': [{'measurements': [{'value': '161.1', 'spread': '83.7', 'groupId': 'OG000'}, {'value': '141.2', 'spread': '68.3', 'groupId': 'OG001'}, {'value': '175.1', 'spread': '36.0', 'groupId': 'OG002'}, {'value': '178.9', 'spread': '28.4', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.2786', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'mg/dL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'The Calories of NCEP Step 2 Diet and Almond Diets', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Whole Almonds', 'description': 'whole almonds to replace 20% daily calorie intake\n\nwhole almonds: Whole almonds will be incorporated into a control diet which is a NCEP step 2 diet. Whole almonds will replace 20% daily calorie intake.'}, {'id': 'OG001', 'title': 'NCEP Step 2 Diet', 'description': 'follow NCEP step 2 diet\n\nNCEP Step 2 diet: follow NCEP step 2 diet'}], 'classes': [{'categories': [{'measurements': [{'value': '1,665.9', 'spread': '153.8', 'groupId': 'OG000'}, {'value': '1,643.4', 'spread': '133.6', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '0.420', 'groupIds': ['OG000', 'OG001'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'the entire study, up to 3 months', 'unitOfMeasure': 'kcal', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Lipid Composition of NCEP Step 2 Diet and Almond Diets', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Whole Almonds', 'description': 'whole almonds to replace 20% daily calorie intake\n\nwhole almonds: Whole almonds will be incorporated into a control diet which is a NCEP step 2 diet. Whole almonds will replace 20% daily calorie intake.'}, {'id': 'OG001', 'title': 'NCEP Step 2 Diet', 'description': 'follow NCEP step 2 diet\n\nNCEP Step 2 diet: follow NCEP step 2 diet'}], 'classes': [{'title': 'PUFA', 'categories': [{'measurements': [{'value': '22.0', 'spread': '4.1', 'groupId': 'OG000'}, {'value': '22.3', 'spread': '4.5', 'groupId': 'OG001'}]}]}, {'title': 'MUFA', 'categories': [{'measurements': [{'value': '30.7', 'spread': '4.0', 'groupId': 'OG000'}, {'value': '12.7', 'spread': '3.3', 'groupId': 'OG001'}]}]}, {'title': 'SFA', 'categories': [{'measurements': [{'value': '11.1', 'spread': '3.3', 'groupId': 'OG000'}, {'value': '9.5', 'spread': '2.6', 'groupId': 'OG001'}]}]}], 'analyses': [{'pValue': '<0.0001', 'groupIds': ['OG000', 'OG001'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'the entire study, up to 3 months', 'unitOfMeasure': 'g', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Body Weight at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '64.7', 'spread': '10.8', 'groupId': 'OG000'}, {'value': '64.8', 'spread': '11.0', 'groupId': 'OG001'}, {'value': '65.3', 'spread': '11.0', 'groupId': 'OG002'}, {'value': '64.7', 'spread': '10.7', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.2412', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'kg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Body Fat Percentage at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '31.6', 'spread': '8.73', 'groupId': 'OG000'}, {'value': '31.4', 'spread': '9.40', 'groupId': 'OG001'}, {'value': '31.0', 'spread': '8.95', 'groupId': 'OG002'}, {'value': '31.7', 'spread': '8.63', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.3837', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'percentage of body weight', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Blood Pressure at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'title': 'SBP', 'categories': [{'measurements': [{'value': '124.2', 'spread': '15.2', 'groupId': 'OG000'}, {'value': '123.6', 'spread': '18.2', 'groupId': 'OG001'}, {'value': '124.5', 'spread': '14.0', 'groupId': 'OG002'}, {'value': '122.1', 'spread': '13.4', 'groupId': 'OG003'}]}]}, {'title': 'DBP', 'categories': [{'measurements': [{'value': '74.9', 'spread': '10.3', 'groupId': 'OG000'}, {'value': '77.3', 'spread': '9.84', 'groupId': 'OG001'}, {'value': '74.9', 'spread': '10.6', 'groupId': 'OG002'}, {'value': '76.5', 'spread': '10.2', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.9784', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'mmHg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Fasting Glucose at the Baseline and the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '146.5', 'spread': '37.9', 'groupId': 'OG000'}, {'value': '139.6', 'spread': '33.1', 'groupId': 'OG001'}, {'value': '140.7', 'spread': '30.9', 'groupId': 'OG002'}, {'value': '140.3', 'spread': '36.8', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.5868', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'mg/dL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Area Under Curve of Plasma Glucose After Eating Standard Breakfast at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '37424', 'spread': '7681', 'groupId': 'OG000'}, {'value': '36415', 'spread': '7250', 'groupId': 'OG001'}, {'value': '35768', 'spread': '7379', 'groupId': 'OG002'}, {'value': '37706', 'spread': '8490', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.1101', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'mg.min/dL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Fasting Insulin at the Baseline and the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '11.2', 'spread': '4.9', 'groupId': 'OG000'}, {'value': '12.3', 'spread': '6.0', 'groupId': 'OG001'}, {'value': '10.4', 'spread': '4.6', 'groupId': 'OG002'}, {'value': '11.8', 'spread': '5.7', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.7823', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'mU/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Area Under Curve of Plasma Insulin After Eating Standard Breakfast at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '3975', 'spread': '2353', 'groupId': 'OG000'}, {'value': '4690', 'spread': '3327', 'groupId': 'OG001'}, {'value': '4055', 'spread': '2964', 'groupId': 'OG002'}, {'value': '4345', 'spread': '2791', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.5570', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'mU.min/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma HbA1c Level at the Baseline and the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '7.47', 'spread': '1.12', 'groupId': 'OG000'}, {'value': '7.45', 'spread': '0.80', 'groupId': 'OG001'}, {'value': '7.51', 'spread': '0.97', 'groupId': 'OG002'}, {'value': '7.39', 'spread': '1.05', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.6263', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'percentage of hemoglubin', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'HOMA at the Baseline and the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '4.00', 'spread': '2.08', 'groupId': 'OG000'}, {'value': '4.24', 'spread': '2.70', 'groupId': 'OG001'}, {'value': '3.58', 'spread': '1.75', 'groupId': 'OG002'}, {'value': '3.98', 'spread': '1.98', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.8328', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'pg/mL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Apolipoprotein Level at the Baseline and the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'title': 'Apo A1', 'categories': [{'measurements': [{'value': '128.9', 'spread': '23.9', 'groupId': 'OG000'}, {'value': '135.1', 'spread': '23.4', 'groupId': 'OG001'}, {'value': '128.3', 'spread': '22.8', 'groupId': 'OG002'}, {'value': '135.3', 'spread': '24.3', 'groupId': 'OG003'}]}]}, {'title': 'Apo B', 'categories': [{'measurements': [{'value': '82.9', 'spread': '22.2', 'groupId': 'OG000'}, {'value': '85.8', 'spread': '24.2', 'groupId': 'OG001'}, {'value': '84.3', 'spread': '23.3', 'groupId': 'OG002'}, {'value': '86.7', 'spread': '22.6', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.7758', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'g/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Nitric Oxide Level at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '59.6', 'spread': '35.8', 'groupId': 'OG000'}, {'value': '72.1', 'spread': '55.3', 'groupId': 'OG001'}, {'value': '62.5', 'spread': '40.9', 'groupId': 'OG002'}, {'value': '50.6', 'spread': '26.7', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.0476', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'μmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Endothelial Function at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'title': 'sE-Selectin', 'categories': [{'measurements': [{'value': '43.4', 'spread': '20.7', 'groupId': 'OG000'}, {'value': '44.0', 'spread': '20.2', 'groupId': 'OG001'}, {'value': '46.1', 'spread': '18.0', 'groupId': 'OG002'}, {'value': '42.3', 'spread': '15.5', 'groupId': 'OG003'}]}]}, {'title': 'ICAM-1', 'categories': [{'measurements': [{'value': '22.3', 'spread': '7.74', 'groupId': 'OG000'}, {'value': '22.9', 'spread': '7.22', 'groupId': 'OG001'}, {'value': '24.0', 'spread': '8.91', 'groupId': 'OG002'}, {'value': '23.1', 'spread': '8.09', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.1205', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'ng/mL', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Protein Carbonyl Level at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '1.00', 'spread': '0.54', 'groupId': 'OG000'}, {'value': '1.06', 'spread': '0.68', 'groupId': 'OG001'}, {'value': '1.00', 'spread': '0.65', 'groupId': 'OG002'}, {'value': '0.72', 'spread': '0.56', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.1512', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'nmol/mg', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Oxide LDL Level at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '32.8', 'spread': '9.9', 'groupId': 'OG000'}, {'value': '34.8', 'spread': '10.9', 'groupId': 'OG001'}, {'value': '33.9', 'spread': '10.9', 'groupId': 'OG002'}, {'value': '35.1', 'spread': '9.9', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.7364', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'U/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Urine Isoproterenol Level at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '12.2', 'spread': '6.19', 'groupId': 'OG000'}, {'value': '14.2', 'spread': '9.22', 'groupId': 'OG001'}, {'value': '11.9', 'spread': '4.24', 'groupId': 'OG002'}, {'value': '12.2', 'spread': '4.68', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.1995', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'ng/mg creatinine', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}, {'type': 'PRIMARY', 'title': 'Plasma Vitamin E Level at the Baseline and at the End of 3-month Dietary Intervention', 'denoms': [{'units': 'Participants', 'counts': [{'value': '33', 'groupId': 'OG000'}, {'value': '33', 'groupId': 'OG001'}, {'value': '33', 'groupId': 'OG002'}, {'value': '33', 'groupId': 'OG003'}]}], 'groups': [{'id': 'OG000', 'title': 'Con Before', 'description': 'before consuming NCEP step II diet'}, {'id': 'OG001', 'title': 'Con After', 'description': 'after consuming NCEP step II diet for 3 months'}, {'id': 'OG002', 'title': 'Alm Before', 'description': 'before consuming almond diet'}, {'id': 'OG003', 'title': 'Alm After', 'description': 'after consuming almond diet for 3 months'}], 'classes': [{'categories': [{'measurements': [{'value': '8.51', 'spread': '3.37', 'groupId': 'OG000'}, {'value': '9.24', 'spread': '5.45', 'groupId': 'OG001'}, {'value': '8.86', 'spread': '4.43', 'groupId': 'OG002'}, {'value': '9.57', 'spread': '5.11', 'groupId': 'OG003'}]}]}], 'analyses': [{'pValue': '0.8528', 'groupIds': ['OG000', 'OG001', 'OG002', 'OG003'], 'ciNumSides': 'TWO_SIDED', 'statisticalMethod': 'Mixed Models Analysis', 'nonInferiorityType': 'SUPERIORITY_OR_OTHER', 'testedNonInferiority': False}], 'paramType': 'MEAN', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention', 'unitOfMeasure': 'μmol/L', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Whole Almonds First, Then NCEP Diet', 'description': 'run in 2 weeks, whole almonds diet Intervention (3 months), Washout (2 weeks), and then NCEP diet Intervention (3 months)'}, {'id': 'FG001', 'title': 'NCEP Diet First, Then Whole Almonds Diet', 'description': 'run in 2 weeks, NCEP diet Intervention (3 months), Washout (2 weeks), whole almonds Intervention (3 months)'}], 'periods': [{'title': 'First Intervention (3 Months)', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '20'}, {'groupId': 'FG001', 'numSubjects': '20'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '16'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '4'}]}], 'dropWithdraws': [{'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '3'}, {'groupId': 'FG001', 'numSubjects': '4'}]}]}, {'title': 'Washout (2 Weeks)', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '16'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '16'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}]}]}, {'title': 'Second Intervention (3 Months)', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '16'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '17'}, {'groupId': 'FG001', 'numSubjects': '16'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '17', 'groupId': 'BG000'}, {'value': '16', 'groupId': 'BG001'}, {'value': '33', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'Almond Diet First, Then NCEP Diet', 'description': 'whole almonds to replace 20% daily calorie intake\n\nwhole almonds: Whole almonds will be incorporated into a control diet which is a NCEP step 2 diet. Whole almonds will replace 20% daily calorie intake.'}, {'id': 'BG001', 'title': 'NCEP Diet First, Then Almond Diet', 'description': 'follow NCEP step 2 diet\n\nNCEP Step 2 diet: follow NCEP step 2 diet'}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Categorical', 'classes': [{'categories': [{'title': '<=18 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Between 18 and 65 years', 'measurements': [{'value': '13', 'groupId': 'BG000'}, {'value': '14', 'groupId': 'BG001'}, {'value': '27', 'groupId': 'BG002'}]}, {'title': '>=65 years', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Gender', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '12', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '20', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '8', 'groupId': 'BG001'}, {'value': '13', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Region of Enrollment', 'classes': [{'title': 'Taiwan', 'categories': [{'measurements': [{'value': '17', 'groupId': 'BG000'}, {'value': '16', 'groupId': 'BG001'}, {'value': '33', 'groupId': 'BG002'}]}]}], 'paramType': 'NUMBER', 'unitOfMeasure': 'participants'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'NONE'}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'CROSSOVER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 40}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2011-11'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2016-11', 'completionDateStruct': {'date': '2014-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2016-11-14', 'studyFirstSubmitDate': '2012-01-13', 'resultsFirstSubmitDate': '2015-10-19', 'studyFirstSubmitQcDate': '2012-08-02', 'lastUpdatePostDateStruct': {'date': '2016-11-16', 'type': 'ESTIMATED'}, 'resultsFirstSubmitQcDate': '2016-01-13', 'studyFirstPostDateStruct': {'date': '2012-08-03', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2016-02-11', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2013-12', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'The Major Nutrients of NCEP Step 2 Diet and Almond Diets', 'timeFrame': 'the entire study, up to 3 months'}, {'measure': 'Plasma Lipid Profiles at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'The Calories of NCEP Step 2 Diet and Almond Diets', 'timeFrame': 'the entire study, up to 3 months'}, {'measure': 'Lipid Composition of NCEP Step 2 Diet and Almond Diets', 'timeFrame': 'the entire study, up to 3 months'}, {'measure': 'Body Weight at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Body Fat Percentage at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Blood Pressure at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Fasting Glucose at the Baseline and the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Area Under Curve of Plasma Glucose After Eating Standard Breakfast at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Fasting Insulin at the Baseline and the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Area Under Curve of Plasma Insulin After Eating Standard Breakfast at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma HbA1c Level at the Baseline and the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'HOMA at the Baseline and the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Apolipoprotein Level at the Baseline and the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Nitric Oxide Level at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Endothelial Function at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Protein Carbonyl Level at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Oxide LDL Level at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Urine Isoproterenol Level at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}, {'measure': 'Plasma Vitamin E Level at the Baseline and at the End of 3-month Dietary Intervention', 'timeFrame': 'at the baseline and at the end of 3-month dietary intervention'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['hyperglycemia', 'hyperinsulinemia'], 'conditions': ['Type 2 Diabetes']}, 'referencesModule': {'references': [{'pmid': '28785295', 'type': 'DERIVED', 'citation': 'Chen CM, Liu JF, Li SC, Huang CL, Hsirh AT, Weng SF, Chang ML, Li HT, Mohn E, Chen CO. Almonds ameliorate glycemic control in Chinese patients with better controlled type 2 diabetes: a randomized, crossover, controlled feeding trial. Nutr Metab (Lond). 2017 Aug 2;14:51. doi: 10.1186/s12986-017-0205-3. eCollection 2017.'}]}, 'descriptionModule': {'briefSummary': 'The purpose of the study is to examine whether almond consumption for 3 month will help Chinese patients with type 2 diabetes control blood glucose and decrease risk factors of cardiovascular disease.', 'detailedDescription': "Our previous study demonstrated almonds (\\~60 g/d) improved lipid profile, glucoregulation, inflammation, and oxidative stress in 20 Chinese patients with type 2 diabetes mellitus (T2DM). To follow-up and expand this work with a more robust trial, the investigators propose a larger (n = 40), longer-term (90-d) investigation of the effect of almonds (\\~60 g/d) on adipokine regulation, endothelial function, glucoregulation, inflammation, lipid profile, and oxidative stress in Chinese patients with T2DM as compared to a placebo control. The investigators will conduct a 7-mo randomized, cross-over, placebo controlled clinical trial in which all meals will be provided to all subjects (n = 40). During the first 2 weeks (run-in period), all subjects will receive a control diet resembling a typical Taiwan diet, prepared based on the NCEP Step 2 guidelines. During the following 3 mo (Phase I), subjects will be randomized to receive either the control diet or the control diet with whole almonds (\\~60g/d) incorporated to replace 20% calories. After a 2-wk washout period during which all subjects will once again receive the control diet, subjects will receive the opposite diet to the one assigned during the Phase I for the other 3 months (Phase II). The caloric content of each diet will be adjusted to each subjects' energy needs to prevent any change in body weight. The following biomarkers will be determined at the baseline and end of each dietary intervention: Glucoregulation: fasted serum HbA1c, glucose and insulin, postprandial serum glucose and insulin, and urinary C-peptide; Endothelial Function: brachial artery FMD and serum nitric oxide, e-selectin, endothelial-1 (ET-1), and intracellular adhesion molecule-1 (ICAM-1); Adipokine Regulation: serum adiponectin, leptin, and resistin; Inflammation: serum high-sensitivity C-reactive protein (CRP), interleukin (IL)-6, IL-10, retinol binding protein-4 (RBP-4), and tumor necrosis factor (TNF)-α; Oxidative Stress: urinary isoprostanes (adjusted for creatinine) and serum protein carbonyls and oxidized LDL; and Lipid Profile: serum cholesterol, triglycerides, and apolipoproteins A1 and B."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '70 Years', 'minimumAge': '40 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* aged between 40-70 years,\n* with BMI = 24-35 kg/m2,\n* HbA1c 6.5-9 %, and\n* regular use of oral hypoglycemic agents.\n\nExclusion Criteria:\n\n* Use of insulin to control blood glucose\n* Regular use of oral steroids\n* Regular use of anti-inflammatory agents (prescribed \\[Rx\\] or over-the-counter \\[OTC\\])\n* Gain or loss of larger than 5% of body weight in the last 6 months\n* CVD: coronary artery disease, left ventricular hypertrophy evidenced by echocardiogram, congestive heart failure, cerebrovascular disease, stroke, peripheral vascular disease, dysautonomia\n* Gastrointestinal: diseases, conditions, or medications influencing gastrointestinal absorption including active peptic ulcer disease, inflammatory bowel disease, treatment with acid-lowering drugs\n* Renal: chronic kidney disease due to any condition, renovascular disease, history of nephrolithiasis, diabetic nephropathy, serum creatinine \\> 1.5 mg/dL\n* Endocrine: disease, untreated thyroid disease, adrenal disease, pheochromocytoma, parathyroid disease, hyperuricemia\n* Rheumatologic: gout, inflammatory arthritis\n* Active treatment for cancer of any type (except basal cell carcinoma) 1 year\n* Systolic blood pressure larger than 150 mmHg, and diastolic blood pressure larger than 95 mmHg.\n* Any history of or known allergies to nuts of any kind\n* Frequent nut consumption, defined as ≥ 3 oz/wk; however, subjects who are willing to refrain from eating all nuts and nut products for 6 wk prior to their initial visit (Visit 1) may be considered eligible\n* Regular use of any dietary supplements containing vitamins, minerals, herbal or other plant-based preparations, fish oil supplements (including cod liver oil) or homeopathic remedies; however, subjects who are willing to refrain from the use of these supplements for 1 mo prior to their initial visit (Visit 1) and throughout the entire study may be considered eligible\n* Usual daily ethanol intake of larger or equal to 2 drinks (24 oz beer, 8 oz wine, 2 oz hard liquor)\n* Illicit drug use\n* Specific laboratory blood or urine analysis parameters of: creatinine larger than 1.5 mg/dL, ALT and AST larger than 1.5 nmol/L, and urinalysis - hematuria and proteinuria'}, 'identificationModule': {'nctId': 'NCT01656850', 'briefTitle': 'The Effect of Whole Almonds on Biomarkers of Cardiovascular Disease in Chinese Patients With Type 2 Diabetes', 'organization': {'class': 'OTHER', 'fullName': 'Taipei Medical University'}, 'officialTitle': 'The Effect of Whole Almonds on Glucoregulation, Endothelial Function, Inflammation, Lipid Profile, and Oxidative Stress in Chinese Patients With Type 2 Diabetes', 'orgStudyIdInfo': {'id': 'PV0805'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Almond diet first, then NCEP Diet', 'description': 'In a 28-wk randomized, cross-over, controlled feeding trial with a 2 week washout between alternative diets, subjects were assigned to receive NCEP or almond diet for 12 weeks after a 2-weeks run-in period', 'interventionNames': ['Other: Almond diet first, then NCEP Diet']}, {'type': 'EXPERIMENTAL', 'label': 'NCEP diet first, then Almond diet', 'description': 'In a 28-wk randomized, cross-over, controlled feeding trial with a 2 week washout between alternative diets, subjects were assigned to receive NCEP or almond diet for 12 weeks after a 2-weeks run-in period', 'interventionNames': ['Other: NCEP diet first, then Almond diet']}], 'interventions': [{'name': 'Almond diet first, then NCEP Diet', 'type': 'OTHER', 'description': 'whole almonds will be incorporated into a control diet which is a NCEP step 2 diet. Whole almonds will replace 20% daily calorie intake. Subjects were assigned to receive almond diet for 12 weeks after a 2-weeks run-in period. After washout 2 weeks, change diet to NCEP Diet for 12 weeks', 'armGroupLabels': ['Almond diet first, then NCEP Diet']}, {'name': 'NCEP diet first, then Almond diet', 'type': 'OTHER', 'description': 'NCEP diet first, then Almond diet. Subjects were assigned to receive NCEP diet for 12 weeks after a 2-weeks run-in period. After washout 2 weeks, change diet to almond diet for 12 weeks', 'armGroupLabels': ['NCEP diet first, then Almond diet']}]}, 'contactsLocationsModule': {'locations': [{'city': 'Taipei', 'country': 'Taiwan', 'facility': 'Taipei Medical University', 'geoPoint': {'lat': 25.05306, 'lon': 121.52639}}], 'overallOfficials': [{'name': 'Jen-Fang Liu, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Taipei Medical University'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Taipei Medical University', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Professor', 'investigatorFullName': 'Jen-Fang Liu', 'investigatorAffiliation': 'Taipei Medical University'}}}}